RIGGS RORY B has filed 52 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 333333 shares of Cibus, Inc. ($CBUS) on January 29, 2026.
Activity breakdown: 2 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | Cibus, Inc. | $CBUS | RIGGS RORY B | Not found | A | Class A Common Stock | 333333 | $1.50 | 14,961,421.0000 | 54,264,505 | 2.28% | 0.61% |
| June 9, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Not found | X | Class A Common Stock | 4000000 | $0.00 | 14,578,088.0000 | 29,659,952 | 37.81% | 13.49% |
| June 9, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Not found | X | Pre-Funded Warrant (right to buy) | 50000 | $0.00 | 0.0000 | 29,659,952 | 100.00% | 0.17% |
| June 9, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Not found | X | Pre-Funded Warrant (right to buy) | 4000000 | $0.00 | 0.0000 | 29,659,952 | 100.00% | 13.49% |
| June 9, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Not found | X | Class A Common Stock | 50000 | $0.01 | 14,628,088.0000 | 29,659,952 | 0.34% | 0.17% |
| June 5, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Not found | A | Class A Common Stock | 5714286 | $1.75 | 10,578,088.0000 | 29,659,952 | 117.49% | 19.27% |
| May 22, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Director | A | Stock Option (Right-to-Buy) | 39301 | $0.00 | 39,301.0000 | 29,659,952 | 9999.99% | 0.13% |
| Jan. 21, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Common Warrant | 4000000 | $0.00 | 4,000,000.0000 | 29,659,952 | 9999.99% | 13.49% |
| Jan. 21, 2025 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Pre-Funded Warrant | 4000000 | $2.50 | 4,000,000.0000 | 29,659,952 | 9999.99% | 13.49% |
| Dec. 31, 2024 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | C | Class A Common Stock | 1388084 | $0.00 | 4,858,619.0000 | 26,429,630 | 40.00% | 5.25% |
| Dec. 31, 2024 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | C | Class B Common Stock | 1388084 | $0.00 | 0.0000 | 26,429,630 | 100.00% | 5.25% |
| Dec. 31, 2024 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | C | Cibus Common Unit | 1388084 | $0.00 | 0.0000 | 26,429,630 | 100.00% | 5.25% |
| Sept. 18, 2024 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 250000 | $4.00 | 3,470,535.0000 | 23,015,417 | 7.76% | 1.09% |
| June 11, 2024 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 98040 | $10.20 | 3,220,535.0000 | 20,567,656 | 3.14% | 0.48% |
| June 11, 2024 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Common Warrant | 98040 | $0.00 | 98,040.0000 | 20,567,656 | 9999.99% | 0.48% |
| Feb. 20, 2024 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | LP interests in RPI US Partners 2019, LP | 30000 | $0.00 | 270,000.0000 | 602,900,000 | 10.00% | 0.00% |
| Feb. 20, 2024 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | Class A Ordinary Shares | 300000 | $0.00 | 420,286.0000 | 602,900,000 | 249.41% | 0.05% |
| Jan. 4, 2024 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | S | Class A Ordinary Shares | 35702 | $27.55 | 120,286.0000 | 602,900,000 | 22.89% | 0.01% |
| Jan. 3, 2024 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | S | Class A Ordinary Shares | 199098 | $27.79 | 155,988.0000 | 602,900,000 | 56.07% | 0.03% |
| Jan. 2, 2024 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | S | Class A Ordinary Shares | 235200 | $28.52 | 355,086.0000 | 602,900,000 | 39.85% | 0.04% |
| Dec. 29, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | C | Class B Common Stock | 1500000 | $0.00 | 1,388,084.0000 | 976,908 | 51.94% | 100.00% |
| Dec. 29, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | C | Class A Common Stock | 1500000 | $0.00 | 3,122,495.0000 | 976,908 | 92.45% | 100.00% |
| Dec. 29, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | J | Cibus Common Units | 1505967 | $0.00 | 2,888,084.0000 | 976,908 | 108.96% | 100.00% |
| Dec. 29, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | C | Cibus Common Units | 1500000 | $0.00 | 1,388,084.0000 | 976,908 | 51.94% | 100.00% |
| Dec. 29, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | J | Class B Common Stock | 1505967 | $0.00 | 2,888,084.0000 | 976,908 | 108.96% | 100.00% |
| Dec. 12, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | J | Pre-Funded Warrant | 50000 | $10.57 | 50,000.0000 | 976,908 | 9999.99% | 5.12% |
| Sept. 27, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | J | Class A Common Stock | 39476 | $0.00 | 2,727,883.0000 | 976,908 | 1.43% | 4.04% |
| Dec. 12, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | P | Class A Common Stock | 517107 | $10.58 | 2,727,883.0000 | 976,908 | 23.39% | 52.93% |
| Nov. 13, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | Class A Ordinary Shares | 475590 | $0.00 | 590,286.0000 | 437,972,000 | 414.65% | 0.11% |
| Nov. 13, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | LP interests in RPI US Partners 2019, LP | 47559 | $0.00 | 300,000.0000 | 437,972,000 | 13.68% | 0.01% |
| Aug. 8, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | G | LP interests in RPI US Partners 2019, LP | 6500 | $0.00 | 347,559.0000 | 437,972,000 | 1.84% | 0.00% |
| June 23, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | A | Class A Ordinary Shares | 7747 | $0.00 | 114,696.0000 | 437,972,000 | 7.24% | 0.00% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 167992 | $0.00 | 3,109,407.0000 | 976,908 | 5.71% | 17.20% |
| June 1, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | P | Class A Common Stock | 1000 | $31.50 | 3,110,407.0000 | 976,908 | 0.03% | 0.10% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class B Common Stock | 1361226 | $0.00 | 4,249,310.0000 | 976,908 | 47.13% | 100.00% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class B Common Stock | 20891 | $0.00 | 2,743,343.0000 | 976,908 | 0.77% | 2.14% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class B Common Stock | 1505967 | $0.00 | 4,249,310.0000 | 976,908 | 54.90% | 100.00% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Cibus Common Units | 1361226 | $0.00 | 4,249,310.0000 | 976,908 | 47.13% | 100.00% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Cibus Common Units | 20891 | $0.00 | 2,743,343.0000 | 976,908 | 0.77% | 2.14% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Cibus Common Units | 1505967 | $0.00 | 4,249,310.0000 | 976,908 | 54.90% | 100.00% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 848662 | $0.00 | 2,804,605.0000 | 976,908 | 43.39% | 86.87% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 118893 | $0.00 | 3,110,407.0000 | 976,908 | 3.97% | 12.17% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 5401 | $0.00 | 2,931,815.0000 | 976,908 | 0.18% | 0.55% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 9600 | $0.00 | 3,110,407.0000 | 976,908 | 0.31% | 0.98% |
| May 31, 2023 | Cibus, Inc. | $CBUS | RIGGS RORY B | Chief Executive Officer | A | Class A Common Stock | 2916 | $0.00 | 2,991,514.0000 | 976,908 | 0.10% | 0.30% |
| May 22, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | S | Class A Ordinary Shares | 1750000 | $32.82 | 106,949.0000 | 437,972,000 | 94.24% | 0.40% |
| May 9, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | Class A Ordinary Shares | 300000 | $0.00 | 1,856,949.0000 | 437,972,000 | 19.27% | 0.07% |
| May 9, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | LP interests in RPI US Partners 2019, LP | 30000 | $0.00 | 354,059.0000 | 437,972,000 | 7.81% | 0.01% |
| March 30, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | S | Class A Ordinary Shares | 130024 | $36.26 | 1,556,949.0000 | 437,972,000 | 7.71% | 0.03% |
| March 29, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | S | Class A Ordinary Shares | 9926 | $36.95 | 1,686,973.0000 | 437,972,000 | 0.58% | 0.00% |
| Feb. 17, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | LP interests in RPI US Partners 2019, LP | 150000 | $0.00 | 384,059.0000 | 437,972,000 | 28.09% | 0.03% |
| Feb. 17, 2023 | Royalty Pharma plc | $RPRX | RIGGS RORY B | Director | C | Class A Ordinary Shares | 1500000 | $0.00 | 1,696,899.0000 | 437,972,000 | 761.81% | 0.34% |